PMC:7696151 / 91800-92017 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2746","span":{"begin":56,"end":59},"obj":"Gene"},{"id":"2756","span":{"begin":85,"end":93},"obj":"Species"},{"id":"2761","span":{"begin":75,"end":78},"obj":"Chemical"}],"attributes":[{"id":"A2746","pred":"tao:has_database_id","subj":"2746","obj":"Gene:1641"},{"id":"A2756","pred":"tao:has_database_id","subj":"2756","obj":"Tax:9606"},{"id":"A2761","pred":"tao:has_database_id","subj":"2761","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"This study showed that the administration of 200 mg/day DCX and 600 mg/day HCQ to 13 patients results in better outcomes (0/13 failures) even after 1 year of treatment, compared to standard antibiotics regimens [155]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T585","span":{"begin":0,"end":217},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This study showed that the administration of 200 mg/day DCX and 600 mg/day HCQ to 13 patients results in better outcomes (0/13 failures) even after 1 year of treatment, compared to standard antibiotics regimens [155]."}